Spyre Therapeutics, Inc. (SYRE)
91.22
+0.26
(+0.29%)
USD |
NASDAQ |
Sep 16, 16:00
91.99
+0.78
(+0.85%)
After-Hours: 19:33
Spyre Therapeutics Price to Book Value : 8.414 for Sept. 16, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 8.389 |
| September 14, 2026 | 8.376 |
| September 11, 2026 | 8.357 |
| September 10, 2026 | 8.183 |
| September 09, 2026 | 8.018 |
| September 08, 2026 | 8.375 |
| September 04, 2026 | 8.208 |
| September 03, 2026 | 8.048 |
| September 02, 2026 | 8.030 |
| September 01, 2026 | 8.163 |
| August 31, 2026 | 8.240 |
| August 28, 2026 | 8.335 |
| August 27, 2026 | 8.635 |
| August 26, 2026 | 8.634 |
| August 25, 2026 | 9.903 |
| August 24, 2026 | 9.838 |
| August 21, 2026 | 9.823 |
| August 20, 2026 | 9.943 |
| August 19, 2026 | 10.05 |
| August 18, 2026 | 9.945 |
| August 17, 2026 | 9.648 |
| August 14, 2026 | 9.559 |
| August 13, 2026 | 9.395 |
| August 12, 2026 | 9.601 |
| August 11, 2026 | 9.477 |
| Date | Value |
|---|---|
| August 10, 2026 | 9.716 |
| August 07, 2026 | 9.677 |
| August 06, 2026 | 9.540 |
| August 05, 2026 | 9.625 |
| August 04, 2026 | 9.680 |
| August 03, 2026 | 8.756 |
| July 31, 2026 | 9.070 |
| July 30, 2026 | 9.362 |
| July 29, 2026 | 9.028 |
| July 28, 2026 | 9.220 |
| July 27, 2026 | 9.228 |
| July 24, 2026 | 9.421 |
| July 23, 2026 | 9.223 |
| July 22, 2026 | 9.148 |
| July 21, 2026 | 9.473 |
| July 20, 2026 | 8.978 |
| July 17, 2026 | 9.245 |
| July 16, 2026 | 8.682 |
| July 15, 2026 | 9.415 |
| July 14, 2026 | 9.127 |
| July 13, 2026 | 8.646 |
| July 10, 2026 | 9.016 |
| July 09, 2026 | 9.109 |
| July 08, 2026 | 8.800 |
| July 07, 2026 | 8.692 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| Incyte Corp. | 3.953 |
| vTv Therapeutics, Inc. | 1.532 |
| BridgeBio Pharma, Inc. | -- |
| Praxis Precision Medicines, Inc. | 6.439 |
Price to Book Value Related Metrics
| Price | 91.22 |
| Earnings Yield | -2.39% |
| Market Cap | 8.033B |